Timber Pharmaceuticals
Dermatology | Timber Pharmaceuticals | United States.
Launch date
Employees
Market cap
$1.2m
Enterprise valuation
($807k) (Public information from Nov 2023)
Share price
$0.0012 TMBR
Woodcliff Lake New Jersey (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 |
---|---|---|---|
Revenues | - | <1m | - |
EBITDA | (17.8m) | (10.7m) | (19.2m) |
% EBITDA margin | - | (3601 %) | - |
Profit | (15.1m) | (10.6m) | (19.4m) |
% profit margin | - | (3597 %) | - |
R&D budget | 15.1m | 6.1m | 13.3m |
R&D % of revenue | - | 2079 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$500k | Grant | ||
Total Funding | $500k |
Related Content
Recent News about Timber Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.